Brevan Howard Capital Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
2025
Q4
$1.11M Sell
2025
Q3
$1.02M Buy
2025
Q1
Sell
2024
Q4
$539K Sell
2024
Q3
$863K Buy
2024
Q2
$504K Buy
2024
Q1
$375K Buy
2023
Q4
$207K Buy